Defining clinically actionable subtypes of castration resistant prostate cancer through epigenetic cell-free DNA analysis

Active Project Grant Awarded Last action

Award ID
HT94252310048
Recipient
Awarding agency
Obligated
$1,382,551

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 84% complete
Originally
Place of performance
Atlanta, GA 30322, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $1,108,860
Amendment -$1,108,860
Original award $1,382,551

Subawards

Subrecipient Amount Awarded
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis Defining clinically actionable subtypes of castration-resistant prostate cancer $13,766
Fred Hutchinson Cancer Center $92,039
Duke University $160,000
Dana-Farber Cancer Institute, Inc. $95,527
Duke University Dr. Halabi will lead and will oversee the statistical analysis of this proposal. Data from the PROPHCEY trial will be used. Dr. Halabi designed and conducted… $35,826

Quick answers

Who received award HT94252310048?

HT94252310048 was awarded to Emory University by Defense Health Agency (Department of Defense) on July 1, 2023.

How much is award HT94252310048 worth?

$1,382,551 has been obligated on HT94252310048.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login